Archives for January 22, 2008

← 2008

Tekturna combo gets US OK

By  Anna Lewcock

Novartis has announced the US approval of its first-in-class blood pressure med Tekturna (aliskiren) combined with a diuretic in a single-tablet formulation.

Icon forays further into Eastern Europe

By  Kirsty Barnes

Dublin-based contract research organisation (CRO) Icon Clinical Research has forayed further into Eastern Europe with the opening of three new offices there.

Fluorotechnics signs up Wako for Japan push

By  Mike Nagle

Australian firm Fluorotechnics wants to bolster the sales of its proteomics products in Japan and so has signed up Osaka firm Wako Pure Chemical Industries to help.

Funding boost for innovative VacciMax platform

By  Anna Lewcock

Canadian vaccine specialist ImmunoVaccine Technologies (IVT) has scored a multi-million dollar grant to go towards developing its potent immune enhancement systems.

GE rattled in Q4 as X-ray business suffers

By  Wai Lang Chu

GE Healthcare has reported its fourth quarter and full year financial results in a tough 12 months that have seen the laboratory imaging and diagnostics company feel the full force of US Government regulatory pressure.